NO975682D0 - Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler - Google Patents

Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler

Info

Publication number
NO975682D0
NO975682D0 NO975682A NO975682A NO975682D0 NO 975682 D0 NO975682 D0 NO 975682D0 NO 975682 A NO975682 A NO 975682A NO 975682 A NO975682 A NO 975682A NO 975682 D0 NO975682 D0 NO 975682D0
Authority
NO
Norway
Prior art keywords
pyridiniminyl
benzisoxazoles
benzisothiazoles
antipsychotics
Prior art date
Application number
NO975682A
Other languages
English (en)
Other versions
NO975682L (no
Inventor
David M Fink
Barbara E Kurys
Gregory M Shutske
Iv John D Tomer
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1996/007319 external-priority patent/WO1996039405A1/en
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO975682D0 publication Critical patent/NO975682D0/no
Publication of NO975682L publication Critical patent/NO975682L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO975682A 1995-06-06 1997-12-05 Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler NO975682L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46602195A 1995-06-06 1995-06-06
US08/637,091 US5668154A (en) 1995-06-06 1996-05-02 Pyridiniminyl-1,2-benzisoxazoles and -benzisothiazoles
PCT/US1996/007319 WO1996039405A1 (en) 1995-06-06 1996-05-14 Pyridiniminyl-1,2-benzisoxazoles and- benzisothiazoles as antipsychotic agents

Publications (2)

Publication Number Publication Date
NO975682D0 true NO975682D0 (no) 1997-12-05
NO975682L NO975682L (no) 1998-02-05

Family

ID=23850131

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975682A NO975682L (no) 1995-06-06 1997-12-05 Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler

Country Status (17)

Country Link
US (3) US5668154A (no)
EP (1) EP0848713B1 (no)
KR (1) KR100309215B1 (no)
AR (1) AR002204A1 (no)
AT (1) ATE197153T1 (no)
AU (1) AU708843B2 (no)
CA (1) CA2224171A1 (no)
DE (1) DE69610778T2 (no)
DK (1) DK0848713T3 (no)
ES (1) ES2153584T3 (no)
GR (1) GR3035249T3 (no)
HU (1) HUP9802571A3 (no)
NO (1) NO975682L (no)
NZ (1) NZ308831A (no)
PT (1) PT848713E (no)
TW (1) TW355710B (no)
ZA (1) ZA964565B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083932A (en) * 1997-04-18 2000-07-04 Cv Technologies Inc. Pharmaceutical compositions derived from ginseng and methods of treatment using same
GT199900185A (es) * 1998-11-06 2001-04-18 Novedosa pirimidin-4-enamina como fungicida.
US6123554A (en) * 1999-05-28 2000-09-26 Berg Technology, Inc. Connector cover with board stiffener
US9907751B2 (en) * 2016-03-10 2018-03-06 RxOMEG Therapeutics LLC Composition and method of use of colchicine oral liquid
US10226423B1 (en) 2017-12-20 2019-03-12 RxOMEG Therapeutics LLC Colchicine drug-to-drug interactions
CN110117278B (zh) * 2018-02-07 2022-07-19 石家庄以岭药业股份有限公司 烷氧基苯并五元(六元)杂环胺类化合物及其药物用途
WO2023083445A1 (en) 2021-11-10 2023-05-19 Symrise Ag Compositions comprising trpm8 agonistic cooling agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds

Also Published As

Publication number Publication date
US5728717A (en) 1998-03-17
TW355710B (en) 1999-04-11
DE69610778D1 (de) 2000-11-30
US5668154A (en) 1997-09-16
DK0848713T3 (da) 2000-12-18
HUP9802571A3 (en) 1999-11-29
DE69610778T2 (de) 2001-06-13
CA2224171A1 (en) 1996-12-12
KR19990022265A (ko) 1999-03-25
US5948798A (en) 1999-09-07
AU5867796A (en) 1996-12-24
NO975682L (no) 1998-02-05
ZA964565B (en) 1996-12-12
EP0848713A1 (en) 1998-06-24
HUP9802571A2 (hu) 1999-08-30
GR3035249T3 (en) 2001-04-30
EP0848713B1 (en) 2000-10-25
ES2153584T3 (es) 2001-03-01
NZ308831A (en) 1998-11-25
AU708843B2 (en) 1999-08-12
AR002204A1 (es) 1998-01-07
KR100309215B1 (ko) 2001-12-28
PT848713E (pt) 2001-02-28
ATE197153T1 (de) 2000-11-15
MX9709450A (es) 1998-06-28

Similar Documents

Publication Publication Date Title
ATE226946T1 (de) Lipidsenkende 1,4-benzothiazepin-1,1-dioxide
FI931278A0 (fi) Polymerer, som innehaoller sulfogrupper
DK0726268T3 (da) Substituerede benzisoxazoler og benzisothiazoler som herbicider
NO965084D0 (no) N-[3(3-cyanopyrazol[1,5-aÅpyrimidin-7-yl)fenylÅ-N-etyl-acetamid
EP0685238A3 (en) Gas mixer.
BR9506532A (pt) 1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas
DE59610836D1 (de) Mittel gegen parasitäre protozoen
EP0836382A4 (en) CRYPTOPHYCINE
DE69722353D1 (de) Reinigungs-, Desinfektions- und Bleichmittelzusammensetzung
NO963526D0 (no) N-metyl-N-[(1S)-1-fenyl-2-((3S)-3-hydroksypyrrolidin-1-yl)-etylÅ-2,2-difenylacetamid
FI930801L (fi) Foerfarande foer behandling av den flora, som kontaminerar pappersbakteriernas vattenomlopp, medelst bakterier
NO984444L (no) Benzothiofener, formuleringer som inneholder de samme og fremgangsmÕter
FI941307A0 (fi) Tjulvalarm, som aktiveras av foeremaolets, som skall skyddas, roerelse
DK0848713T3 (da) Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som antipsykotiske midler
TR199601012A2 (tr) Sampuan terkibi.
NO982304D0 (no) 25-Hydroksy-16-ene-26,27-bishomo-cholecalciferoler
DK1240163T3 (da) 3-(4,5-Dihydroisoxazol-5-yl)-benzoylpyrazoler
FI930217A7 (fi) Hoegt tvaerbundna, smaott avdunstande organiska foereningar innehaollande ytbelaeggningskompositioner som omfattar polyuretandispersioner
ES1032571Y (es) Gafa,
BR9510036A (pt) Derivados de 1,3,4-oxadiazina
BR9508248A (pt) 1,2,4,6-Tiatriazinas herbicidas
BR9609606A (pt) Agente antipiroplasmático
FI931345A0 (fi) Tjuvalarm, som aktiveras av foeremaolets, som skall skyddas, roerelse
BR9610047A (pt) 1,3,4-oxadiazolin-2-onas
FR2705573B1 (fr) Stérilisateur.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application